Business Wire

iProov and Eurostar Launch Trial to Provide Contactless Travel at London St Pancras International

Share

iProov, the world leader in biometric face authentication technology, and Eurostar, the high-speed passenger rail service linking the UK with mainland Europe, have announced that their trial of a contactless fast-track service, SmartCheck, is now live.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211205005029/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

iProov and Eurostar announce contactless travel trial is live at London St Pancras International (Photo: Business Wire)

SmartCheck enables passengers to complete secure ticket verification and UK exit check on their mobile devices prior to travel. As part of the trial, Business Premier and Carte Blanche ticket holders will be able to scan their identity documentation using their iPhones before arriving at the station, completing a brief biometric face scan to verify that they are the genuine holder of the identity document. The biometric face verification, which uses iProov’s Genuine Presence Assurance technology, is then linked to their e-ticket, with confirmation sent to the passenger.

On arrival at St Pancras International station, passengers proceed through a dedicated SmartCheck lane. A brief face scan at the ticket gate verifies that the customer has completed the ticket check, with no sharing of paper or electronic tickets needed. A second face scan at the UK Exit Check allows Eurostar to verify that the passenger has completed their passport information, again replacing the need for travelers to hand over documentation.

SmartCheck aims to revolutionize the travel experience by making it completely effortless for the passenger, while maximizing privacy and increasing reassurance through improved security. The aim is to eliminate queues and expedite the boarding process to further improve customer satisfaction, especially for frequent travelers.

The concept is being brought to train travel as part of the First of a Kind 2020 competition run by Innovate UK, funded by the Department for Transport (DfT). The initiative supports research, development and innovation in the UK rail industry. At this time, the trial involves a limited number of invited passengers and is focused on the check-in and exit control processes operated by Eurostar at St Pancras Station and not the UK or Schengen Entry controls.

“This secure, convenient and privacy-protecting technology will make life easier and safer for travelers around the world,” said Andrew Bud, Founder and CEO, iProov. “The days of rooting around in your bag for your passport or hoping that your phone battery doesn’t run out before you show your e-ticket at the gate are over. It’s effortless and convenient while also delivering the reassurance and security that travelers expect.”

“We are committed to working closely with governments to introduce new tools and technology that streamline the check in and border process,” said Gareth Williams, Strategy Director and Company Secretary, Eurostar. “Face biometric technology, which we start trialling today, is a fast and contactless solution which will enable secure passenger checks to take place more efficiently and provide a seamless start to the Eurostar customer journey.”

“Our investment into the First of a Kind competition, supporting ingenious inventions on our rail network, is driving real-world innovations as we build the railway of tomorrow,” said Grant Shapps, Transport Secretary. “The brand new contactless travel technology from iProov and Eurostar is a window into the future of border control, of smoother, more seamless and convenient journeys.”

iProov’s Genuine Presence Assurance technology enables organizations to securely verify the identity of consenting online individuals in a way that is completely effortless for the user. A brief, multi-dimensional biometric face scan combines light, time and space to verify that a remote user is the right person, a real person, and that they are authenticating in real time. This highly secure process, supported by iProov’s active threat management system, protects against spoof attacks and can be used on any smartphone, tablet or computer with a user-facing camera.

The trial was developed in close partnership with Eurostar and WorldReach Software, now part of global identity and data security company, Entrust. All personal data is processed in compliance with GDPR law, with full passenger consent. It is not shared with any party outside the trial and is deleted within six hours of the user travelling.

iProov technology is in use throughout the world, with customers including the US Department of Homeland Security, the UK Home Office, the NHS, the Australian Taxation Office, the Singapore Government and many banks and enterprises.

About iProov

Launched in 2013, iProov is the world leader in online facial biometric authentication, working with governments, banks and other enterprises to securely verify customer identity. Used for effortless onboarding and authentication, customers include the U.S. Department of Homeland Security, the UK Home Office, the UK National Health Service (NHS), the Australian Taxation Office, GovTech Singapore, Rabobank, ING, and others. iProov’s technologies include Liveness Assurance and Genuine Presence Assurance, which ensures that an online customer is the right person, a real person, and is authenticating right now. This protects against spoof attacks from photos, videos, masks and digital injection attacks and the emerging threat of deepfakes. iProov was recognized as a Gartner Cool Vendor 2020 in Identity Access Management & Fraud Detection. For more information, please see www.iproov.com or follow us on LinkedIn or Twitter.

About Eurostar

For more information, please contact press.office@eurostar.com

Eurostar is the high-speed passenger service linking London St. Pancras International with city centre stations in mainland Europe, via the Channel Tunnel. Eurostar was established in 1994 as a partnership between three railway companies: SNCF, SNCB and LCR (London and Continental Railways). On 1 September 2010, Eurostar became a single, unified corporate entity owned by three shareholders: SNCF, SNCB and LCR. LCR’s holding was transferred to the Treasury in 2014 and sold by the UK government to a consortium comprising Caisse de Depot et Placement du Quebec (CDPQ) and Hermes Infrastructure in May 2015.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Rob Tacey
rob.tacey@iproov.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

IonQ Unanimously Appoints Peter Chapman as Next Chairman of the Board of Directors26.4.2024 14:30:00 EEST | Press release

IonQ (NYSE: IONQ), a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ’s upcoming Annual General Meeting on June 5, 2024. Both appointments were disclosed in a proxy statement issued on April 25, 2024. Peter Chapman has also been nominated for re-election as a Class III director at the meeting, and his chairmanship will take effect assuming he is re-elected. “Last quarter we were delighted to have appointed Robert Cardillo and Bill Scannell to our Board of Directors. In addition, the Board unanimously appointed Peter Chapman to serve as its next Chairman following the annual meeting given his half-decade worth of contributions to IonQ and his strong progress transitioning IonQ from an academic to a commercial company,” said Niccolo de Masi, Chairman of the Nominating & Corporate Governance Committee of IonQ’s Board. “Unde

Sealing System launches: XIO – Intelligent Farming26.4.2024 13:17:00 EEST | Press release

XIO – Intelligent Farming, specializes in logistics systems for insect protein production. XIO is a new business unit within Sealing System A/S, one of the leading providers of automated end-of-line packaging lines in Scandinavia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240426832303/en/ Robotic solution handling Black Soldier Fly Larvae (Photo: Business Wire) “At Sealing System A/S, we believe that practical innovation is the engine of real-world change. With the establishment of, XIO - Intelligent Farming, we are setting new industry standards, emphasizing the importance of intralogistics in the field of insect protein production, and proudly leading the way.” Ole Jensen CEO, Sealing System A/S XIO – Intelligent Farming provides solutions serving various aspects of the insect production, including fully automatic logistics systems, comprehensive data tracking, transfer trolleys and shuttles, as well as robot systems

Tecnotree Achieves Strong Q1 2024 Results with Sustained Revenue Growth and Enhanced Profitability26.4.2024 11:46:00 EEST | Press release

Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced its financial results for the first quarter of 2024, demonstrating solid growth with a 4.7% increase in revenue. The company maintained its momentum in driving global sales of its digital platform, in the first quarter of 2024, completing many AIML and digital transformations to key customers, resulting in a significant increase in revenue. The growth was primarily driven by new wins in the LATAM region, while EMEA and APAC regions remain growing markets for the digital platform. Key Q1 Highlights of the financial results: Net sales increased 4.7% to EUR 16.3 (15.5) million. Operating results increased by 22.3% to EUR 4.4 (3.6) million. Earnings per share EUR 0.01 (0.01). Order book at the end of the period increased by 10.3% to EUR 74.8 (67.8) million. Tecnotree achieved several notable milestones in the first quarter. The company solidified its position as a trusted par

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye